CENCORA, INC. Proceeds from Sale of Productive Assets
CENCORA, INC. (COR) reported Proceeds from Sale of Productive Assets of $45.82 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2026-08-05
- 2026-06-30: Proceeds from Sale of Productive Assets 9 month $45.82M.
- 2025-06-30: Proceeds from Sale of Productive Assets 9 month $0.00.
| Period end | Proceeds from Sale of Productive Assets 9 month |
|---|---|
| 2026-06-30 | $45.82M 10-Q · filed 2026-08-05 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |